- AdventHealth
Dr. C. Josef Ghosn is inaugurated as president and CEO of the rapidly growing university.
ORLANDO, Fla., Feb. 15, 2024 —In the presence of local and national dignitaries, students, alumni, and faculty today, AdventHealth University inaugurated C. Josef Ghosn, EdD, FACHE, its third president and CEO.
“Today is a special day for me and for my family, but most importantly, this is an important moment for our students, who are at the heart of all we do,” Dr. Ghosn shared with more than 500 guests at Forest Lake Seventh-day Adventist Church in Apopka this afternoon. “AHU is a very special place, where we have a unique opportunity to develop highly skilled health professionals who will practice health care as a ministry and make a tremendous impact on the lives of patients and their families.”
Dr. Ghosn, who joined AHU in May 2023, has extensive leadership experience in health care administration. Most recently, he served as vice president of strategic planning for AdventHealth’s Multistate Division and prior to that, as AdventHealth Florida Division’s senior vice president for strategic planning. Dr. Ghosn was a tenured professor and associate dean of academic affairs at Atlantic Union College. He also served as a professor of business and education at Southern Adventist University and as an adjunct professor of healthcare administration at AdventHealth University. Dr. Ghosn holds a doctoral degree in educational leadership from the University of Massachusetts Lowell and a master of business administration degree with a Healthcare Administration emphasis from Andrews University.
“This is a special milestone in the history of AdventHealth University,” said Randy Haffner, PhD, president and CEO of AdventHealth Florida and chair of AHU’s Board of Trustees. “As we inaugurate Dr. C. Josef Ghosn, we begin a pivotal time in the life of this institution. New degrees and workforce certificates continue to be added, student enrollment is increasing, plans for expanding the current campuses are under way, and new campuses are being explored – ambitious growth plans to help our nation solve nurse and provider shortages. This means more caregivers can fulfill their calling to provide hope and healing and join a growing workforce specially trained in whole-person care.”
AHU’s former presidents are Edwin I. Hernandez, PhD, and David Greenlaw, DMin.
As at many official university ceremonies, faculty and presenters donned regalia and a transfer of the mace and presidential medallion took place. Mentors, colleagues, and students provided words of hope, sharing stories from throughout Dr. Ghosn’s career.
AdventHealth University, with campuses in Orlando and Denver, was founded in 1992 and has graduated more than 10,000 students who live the healing values of Christ locally and globally. Today, the university is poised for significant increase in student enrollment. It also maintains ambitious plans to begin expanding its Orlando campus footprint and open an additional Florida campus in the next 12 months.
Recent News
AdventHealth Cancer Institute Advances the Use of CAR T-Cell Therapy for Multiple Myeloma
CAR-T therapies have emerged as new treatment options for certain types of cancer through a one-time infusion that can lead to long-lasting remission.
New Clinical Trial Explores Digital Intervention for Apathy in Late-life Depression
Afflicting 30-50% of patients with late-life depression, apathy is a challenging psychiatric syndrome in older adulthood that can result in lack of motivation leading to poor self-care, physical...
AdventHealth Performs Central Florida’s First Liver Transplant for Unresectable Colorectal Liver Metastases
In June 2025, AdventHealth Abdominal Transplant Surgeon and Surgical Oncologist Ryan Day, MD, worked with a multidisciplinary team to perform Central Florida’s first liver transplant for unresectable...
AdventHealth Neuroscience Institute First in Florida to be Recognized as a GammaTile Center of Excellence
GammaTile is the first and only tile-based radiation therapy for the treatment of
operable brain tumors. The AdventHealth Neuroscience Institute began performing GammaTile procedures in 2021 and was...
An AdventHealth Collaboration Explores the Impact of Microgravity and Electrical Stimulation on Muscle Cell Health in Space
Using a muscle lab-on-chip model aboard the International Space Station (ISS), AdventHealth Translational Research Institute’s Dr. Paul Coen has been working with a multidisciplinary team from the...
AdventHealth Neuroscience Institute Among First in U.S. to Offer Phase IIa Clinical Trial of Troculeucel for Moderate Alzheimer’s Disease
While most clinical trials for Alzheimer’s disease have focused on patients with early or mild cognitive impairment, roughly 30% of those with Alzheimer’s have moderate stage disease for which there...
AdventHealth Translational Research Institute Selected as Clinical Site for National Study of Muscle, Mobility and Aging (SOMMA)
Under the leadership of Scientific Director and Principal Investigator Bret H. Goodpaster, PhD, the AdventHealth Translational Research Institute (TRI) is now enrolling men and women 70 years of age...
AdventHealth Neuroscience Institute Administers First Dose of Investigative NK Cell Therapy to Person with Alzheimer’s Disease
Under a single compassionate use Investigational New Drug (IND) authorization cleared by the U.S. Food and Drug Administration (FDA), the AdventHealth Neuroscience Institute worked with NKGen Biotech...
AdventHealth Study Exploring the Use of MR-Guided Focused Ultrasound (MRgFUS) to Disrupt the Blood-Brain Barrier for Treatment of Alzheimer’s Disease
Under the leadership of Dr. Valeria Baldivieso and Dr. Chandan Reddy, the AdventHealth Research Institute is the first and only site in Orlando offering the Exablate Blood-Brain Barrier (BBB)...
AdventHealth Research Institute Offers Phase II Clinical Trial of Etanercept for Treatment of Blast-Induced Tinnitus
Approximately 1 billion people throughout the world suffer from tinnitus (ringing in the ears), and it is the number one disability of those who serve in the U.S. military. The condition can disrupt...
AdventHealth Research Institute and NESTRE Health & Performance Announce Collaboration to Advance Neurocognitive Health and Performance Through Cognitive Training
With an aging population and increases in the prevalence of neurological conditions like Alzheimer’s disease and dementia, physicians and patients alike continue to seek new tools and approaches to...
Empowering emerging women leaders
ATHENA NextGen’s Karen Keene joins AdventHealth’s Karen Corbin in a discussion about empowering the next wave of women leaders.